SynthesisSeminars in thrombosis and hemostasis2014
ABO blood group and vascular disease: an update.
Synthesis in Seminars in thrombosis and hemostasis, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 45 papers, 4 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
45 citing papers in PubMed, 4 syntheses or guidelines pooled it, 95 citations in OpenAlex.
- ABO and Rhesus blood groups and multiple health outcomes: an umbrella review of systematic reviews with meta-analyses of observational studies.BMC medicine · 2024Pooled it
- Association Between ABO Blood Group and Venous Thromboembolism Risk in Patients With Peripherally Inserted Central Catheters: A Meta-analysis and Systematic Review.Frontiers in oncology · 2022Pooled it
- Relationship between ABO blood group and pregnancy complications: a systematic literature analysis.Blood transfusion = Trasfusione del sangue · 2016Pooled it
- ABO blood group system and the coronary artery disease: an updated systematic review and meta-analysis.Scientific reports · 2016Pooled it
- ABO blood group in primary antiphospholipid syndrome: influence in the site of thrombosis?Journal of thrombosis and thrombolysis · 2015Trial
- ABO Blood Group and Biomarker-Based Risk in Acute Pulmonary Embolism: A Retrospective Cohort Study.Journal of clinical medicine · 2026Article
- Pulmonary Embolism and ABO Blood Type: A Systematic Review.Diagnostics (Basel, Switzerland) · 2025Review
- Differential expression ofJournal of Taibah University Medical Sciences · 2024Article
- Non-O blood types are associated with a greater risk of large artery atherosclerosis stroke and dysregulation of cholesterol metabolism: an observational study.Lipids in health and disease · 2024Observational
- Blood group AB is associated with reduced blood loss but also elevated cardiovascular mortality in aortocoronary bypass surgery.Journal of thrombosis and thrombolysis · 2024Article
- Association between ABO blood type and coronavirus disease 2019 severe outcomes across dominant variant strains.Journal of the American College of Emergency Physicians open · 2024Article
- Associations Between ABO Blood Groups and Diseases in the Digestive System and Vein.International journal of general medicine · 2024Article
- Article
- The Clinical Utility of ABO and RHD Systems as Potential Indicators of Health Status, a Preliminary Study in Greek Population.Clinics and practice · 2022Article
- ABO Blood Type Is Associated with Thrombotic Risk in Patients with Nonvalvular Atrial Fibrillation.Journal of clinical medicine · 2022Article
- Variation in COVID-19 Disease Severity and Clinical Outcomes Between Different ABO Blood Groups.Cureus · 2022Article
- The Potential Impact of Blood System on Dietary Habits and Smoking.Medicines (Basel, Switzerland) · 2022Article
- The morbidity and mortality of COVID-19 are associated with ABO and Rh blood groups.European journal of preventive cardiology · 2021Article
- ABO blood groups do not predict progression of traumatic intracranial hemorrhage.Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia · 2021Article
- Associations between smoking and blood-group, and the risk of dyslipidaemia amongst French women.Scientific reports · 2021Article
Corrections and comments
- Commented on by
Authors and funding
5 authors at 2 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
It has been well known for many years that the ABO blood group has a major influence on hemostasis, through its influence on von Willebrand factor and, consequently, factor VIII plasma levels. Although the relationship between non-O blood type and the risk of venous thromboembolism is nowadays also well established, the association with arterial thrombotic events (i.e., myocardial infarction [MI] and ischemic stroke) is less well characterized. To elucidate the latter issue, we have conducted a systematic review and meta-analysis of the existing literature. After an electronic search strategy using MEDLINE and EMBASE and a manual review of abstract books of the International Society on Thrombosis and Haemostasis and of reference lists of all retrieved articles, 28 studies were finally included in our systematic review. The prevalence of non-O blood group was significantly higher in patients with MI (pooled odds ratio [OR]: 1.28, 95% confidence interval [CI]: 1.17-1.40; p < 0.001) and ischemic stroke (pooled OR: 1.17, 95% CI: 1.01-1.35; p = 0.03) than in controls. The restriction of the analysis to high quality studies only confirmed the association with MI (pooled OR: 1.17, 95% CI: 1.03-1.32) but not with ischemic stroke (pooled OR: 1.28, 95% CI: 0.94-1.74). In conclusion, the results of our meta-analysis confirm the existing literature evidence of a weak association between non-O blood group and vascular arterial thrombosis, in particular myocardial ischemia.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.